Fulcrum Therapeutics discontinues its pociredir program after the Food and Drug Administration raises concerns.

By Siddhi Mahatole June 2 (Reuters) - Shares of Fulcrum Therapeutics plunged 52% on Tuesday after the company said it would ...

Fulcrum’s setback is the latest in a series of stumbles for the developers of sickle cell medicines, among them Pfizer, ...

The Foundation for Sickle Cell Disease Research (FSCDR) welcomes critically revered, award-winning actress, producer, ...

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared ...

Afimmune Reports Positive Phase 2 Results for Epeleuton in Sickle Cell Disease, Reducing Vaso-Occlusive Crisis Rate by ...

June 1 (Reuters) - Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug after the U.S. Food and Drug Administration raised cancer-risk concerns, which ...

Exclusive: Demand for blood to treat the rare disorder has soared by 132% in 10 years ...

Montgomery County sheriff’s investigators arrested Jeremy Michael Buckner, 35, of Porter, in connection with a fatal hit-and-run on U.S. Highway 59. Detectives arrest Porter man in deadly hit-and-run ...

Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions globally, especially in India's tribal and rural populations. According to the World Health Organisation (WHO), it is one of ...

State Rep. Omari Crawford discusses a new Georgia law designed to expand oversight and improve access to care for people ...